← Back to Caplin Point Laboratories Ltd Overview
📊Financials📈PE Ratio🥧Shareholding💰Dividend📋Quarterly⚖️Balance Sheet💹P&L🌊Cash Flow
CAPLIPOINTPharmaceuticals

Caplin Point Laboratories Ltd — Financial Ratios & Key Metrics

₹1504.80
-3.75%
P/E Ratio24.62xIndustry: 31.77x
ROE22.66%Return on equity
ROCE25.85%Return on capital
Debt/Equity0.00Debt free ✓
💎

Valuation & Profitability

P/E Ratio
24.62x
Industry Average P/E
31.77x
Dividend Yield
0.31%
Market Cap
₹14.50K (Cr)
Sales Growth 5Y
17.55%
Profit Growth 5Y
20.48%
EPS Growth 5Y
20.36%
OPM 5Y Avg
31.89%
📉

Price Returns

1 Month
-6.09%
3 Months
-10.26%
6 Months
-11.56%
1 Year
-13.08%
52W Low
₹1549
Current
₹1505
52W High
₹2395
-5% of 52-week range — Near lows
🔬

Technical Indicators

32RSI 14
Neutral
Momentum is balanced — neither overbought nor oversold.
SMA 50
₹1719
▼ Price below SMA 50 — Bearish
SMA 200
₹1954
▼ Long-term downtrend
Volume Signal
168% of avg
Above average volume — strong conviction behind price move

Technical indicators are for educational purposes only. Not investment advice.

More on Caplin Point Laboratories Ltd

OverviewFinancialsPE HistoryShareholdingQuarterlyBalance SheetP&LCash FlowPharmaceuticals StocksScreener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.